Bioptimus raised €32M in a Seed round in Feb 2024. The company is based in Paris, France. Investors in the round: Bpifrance, Cathay Innovation, Frst and 5 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.